BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2023 1:19:28 PM | Browse: 617 | Download: 1245
Publication Name World Journal of Clinical Cases
Manuscript ID 79704
Country Egypt
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19
Manuscript Source Invited Manuscript
All Author List Mai Hashem and Mohamed El-Kassas
ORCID
Author(s) ORCID Number
Mohamed El-Kassas http://orcid.org/0000-0002-3396-6894
Funding Agency and Grant Number
Corresponding Author Mohamed El-Kassas, MD, Professor, Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, Helwan, Cairo 11795, Egypt. m_elkassas@hq.helwan.edu.eg
Key Words COVID-19; Liver transplantation; Recipient; Protocols; Outcomes
Core Tip Liver transplant (LT) patients infected with severe acute respiratory syndrome coronavirus 2 have clinical, biochemical, and radiological features highly comparable to those of immunocompetent patients, except for a higher incidence of gastrointestinal symptoms. The prognosis of LT recipients is similar to non-LT patients and is not significantly affected by immunosuppression but rather by comorbidities. Considering the risk of organ rejection, it may not be wise to stop all immunosuppression after a coronavirus disease 2019 diagnosis. All LT recipients should be vaccinated, considering booster doses augment vaccination immunogenicity. Still, a considerable proportion of patients remain at risk for coronavirus disease 2019. Therefore, social isolation and other precautions must be maintained.
Publish Date 2023-03-30 13:19
Citation Hashem M, El-Kassas M. Diagnosis, treatment protocols, and outcomes of liver transplant recipients infected with COVID-19. World J Clin Cases 2023; 11(10): 2140-2159
URL https://www.wjgnet.com/2307-8960/full/v11/i10/2140.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i10.2140
Full Article (PDF) WJCC-11-2140.pdf
Full Article (Word) WJCC-11-2140.docx